Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Haydale Graphene Industries PLC (HAYD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.435 -0.005    -1.15%
22/04 - Closed. Currency in GBP ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BKWQ1135 
SEDOL:  BKWQ113
  • Volume: 173,249
  • Bid/Ask: 0.420 / 0.440
  • Day's Range: 0.430 - 0.440
Haydale 0.435 -0.005 -1.15%

LON:HAYD Financials

 
A brief overview of the LON:HAYD financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Haydale Graphene Industries PLC over time.

Haydale Graphene Industries plc reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was GBP 2.47 million compared to GBP 1.78 million a year ago. Net loss was GBP 2.39 million compared to GBP 2.83 million a year ago. Basic loss per share from continuing operations was GBP 0.01 compared to GBP 0.01 a year ago. Diluted loss per share from continuing operations was GBP 0.01 compared to GBP 0.01 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

HAYD Income Statement

Gross margin TTM 57.27%
Operating margin TTM -102.15%
Net Profit margin TTM -114.94%
Return on Investment TTM -34.1%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 1.23 1.23 1.26 1.26
Gross Profit 0.703 0.703 0.724 0.724
Operating Income -1.16 -1.16 -1.38 -1.38
Net Income -1.2 -1.2 -1.48 -1.48

HAYD Balance Sheet

Quick Ratio MRQ 2.01
Current Ratio MRQ 3.16
LT Debt to Equity MRQ 12.1%
Total Debt to Equity MRQ 33.24%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 14.46 14.46 12.89 12.89
Total Liabilities 5.33 5.33 5.92 5.92
Total Equity 9.14 9.14 6.97 6.97

HAYD Cash Flow Statement

Cash Flow/Share TTM 0
Revenue/Share TTM 0
Operating Cash Flow  -48.37%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -1.04 -1.04 -0.484 -0.484
Cash From Investing Activities -0.089 -0.089 -0.166 -0.166
Cash From Financing Activities 2.09 2.09 -0.11 -0.11
Net Change in Cash 0.961 0.961 -0.796 -0.796
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

HAYD Comments

Write your thoughts about Haydale Graphene Industries PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alessandro Bordini
Alessandro Bordini Jan 23, 2023 4:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Haydale (AIM: HAYD), the global technology solutions company, is delighted to announce that it has been shortlisted for The Engineer’s Collaborate to Innovate Awards (C2I) for its work with the Wales Kidney Research Unit (“WKRU”) at Cardiff University on a microRNA sensor for kidney transplant patients.The collaborative team including Haydale, WKRU, Cardiff University Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff University School of Chemistry, Cardiff and Vale University Health Board and University Hospital of Wales are one of six finalists in the Healthcare and Medical Category for The Engineer’s seventh annual C2I Awards.Already a winner of the Kidney Research UK MedTech Competition, the urinary electrochemical microRNA sensor has the potential to replace slower and more costly PCR-based methods for the rapid detection of problems with newly transplanted kidneys. The sensor uses Haydale’s biomedical functionalised graphene ink to accelerate detection without the need for an invasive biopsy.This nomination will support the commercial progress that Haydale is making with its biosensor inks, which have been focused on diabetes monitoring and management. It is anticipated that this will be expanded to wider diagnostics as the technology is adopted.Keith Broadbent, Haydale’s CEO, said he was delighted the team’s hard work had been recognised, commenting:“This is further recognition of our work in healthcare. Our collaboration has helped to accelerate the provision of cutting-edge technological solutions to improve people’s life experience. Using functionalised graphene reduces sensor production time and variability and accelerates translation to improve patient outcomes.
Reply
2 0
Report
gary lee
JustinCredible Feb 13, 2021 5:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
deffo one of the better graphene plays.holding like a baby
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email